Clinical Trial Update: A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a triple-combination regimen of Prusogliptin, Dapagliflozin, and extended-release Metformin for type 2 diabetes; the trial is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Metformin hydrochloride extended-release (metformin extended-release)
• Prusogliptin (prusogliptin)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING